Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson

Last Updated: May 28, 2023

ULTRAM Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

Which patents cover Ultram, and what generic alternatives are available?

Ultram is a drug marketed by Janssen Pharms and Valeant Pharms and is included in two NDAs.

The generic ingredient in ULTRAM is tramadol hydrochloride. There are thirty-six drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the tramadol hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Ultram

A generic version of ULTRAM was approved as tramadol hydrochloride by SUN PHARM INDS INC on June 19th, 2002.

  Try a Trial

Summary for ULTRAM
Drug patent expirations by year for ULTRAM
Drug Prices for ULTRAM

See drug prices for ULTRAM

Drug Sales Revenue Trends for ULTRAM

See drug sales revenues for ULTRAM

Recent Clinical Trials for ULTRAM

Identify potential brand extensions & 505(b)(2) entrants

Henry Ford Health SystemPhase 4
Medical College of WisconsinPhase 2
BayerPhase 4

See all ULTRAM clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for ULTRAM

US Patents and Regulatory Information for ULTRAM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Janssen Pharms ULTRAM tramadol hydrochloride TABLET;ORAL 020281-002 Mar 3, 1995 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Valeant Pharms ULTRAM ER tramadol hydrochloride TABLET, EXTENDED RELEASE;ORAL 021692-002 Sep 8, 2005 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Janssen Pharms ULTRAM tramadol hydrochloride TABLET;ORAL 020281-001 Mar 3, 1995 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.